Homology
The following BLAST results are available for this feature:
InterPro
Analysis Name: InterProScan on OGS1.0
Date Performed: 2022-09-29
| IPR Term | IPR Description | Source | Source Term | Source Description | Alignment |
|---|
| IPR003591 | Leucine-rich repeat, typical subtype | SMART | SM00369 | LRR_typ_2 | coord: 206..229
e-value: 18.0
score: 11.3
coord: 255..278
e-value: 32.0
score: 9.1
coord: 113..138
e-value: 110.0
score: 4.6
coord: 69..91
e-value: 38.0
score: 8.5
coord: 162..186
e-value: 290.0
score: 1.3 |
| IPR001611 | Leucine-rich repeat | PFAM | PF13855 | LRR_8 | coord: 116..175
e-value: 2.2E-10
score: 40.1 |
| IPR032675 | Leucine-rich repeat domain superfamily | GENE3D | 3.80.10.10 | Ribonuclease Inhibitor | coord: 116..183
e-value: 3.4E-18
score: 67.7
coord: 21..115
e-value: 1.4E-11
score: 46.3 |
| IPR032675 | Leucine-rich repeat domain superfamily | GENE3D | 3.80.10.10 | Ribonuclease Inhibitor | coord: 184..315
e-value: 5.2E-31
score: 109.5 |
| None | No IPR available | PANTHER | PTHR48005:SF10 | LEUCINE-RICH REPEAT RECEPTOR-LIKE TYROSINE-PROTEIN KINASE PXC3 ISOFORM X1 | coord: 34..141
coord: 116..309
coord: 73..249 |
| None | No IPR available | PANTHER | PTHR48005 | LEUCINE RICH REPEAT KINASE 2 | coord: 116..309 |
| None | No IPR available | PANTHER | PTHR48005 | LEUCINE RICH REPEAT KINASE 2 | coord: 34..141
coord: 73..249 |
| None | No IPR available | SUPERFAMILY | 52058 | L domain-like | coord: 33..307 |
Alignments
The following features are aligned
Analyses
This polypeptide is derived from or has results from the following analyses
Relationships
This polypeptide derives from the following mRNA feature(s):
Sequences
The following sequences are available for this feature:
polypeptide sequence >prot_C-australica_Contig_1031.1.3 ID=prot_C-australica_Contig_1031.1.3|Name=mRNA_C-australica_Contig_1031.1.3|organism=Chrysoparadoxa australica CS_1217|type=polypeptide|length=332bp
MLFEGLAGPRWKEKKGWLGRAGTPNQRGVEPFSCHPSLWTGVSTDMGHIT
ALHLANLGAEGKVKGLEPLLHLISLDLSWNQVHEIPMAIAMLKRLEILKI
SAAGMRGPLPKSLPISLRELDLRHNSLEGEIPEAILKCKKLSVLNLGQNC
FTGGIPGAIGQLVSLRELRLSCNLLTGAIPPLPLNLQILDLSRNKLDGSF
PKVGELAKLRELRMSNNQLTGTLTGVGLGELTTLVMLYAADNRLRGPLPP
ELFSLKELRFLNLQRNHLEGAVPATIGNLDKLVALVLCGNKLVSPLPSTL
ARLSKLSDMAILSGTPSRMAGVKRGFTKHGT* back to top
Annotated Terms
The following terms have been associated with this polypeptide:
|